Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.93bn	860.53	n/a
MSBMesoblast	AU$1.10bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$989.51m	n/a	n/a
IMUImugene	AU$587.87m	n/a	n/a
IMMImmutep	AU$517.14m	n/a	n/a
OPTOpthea	AU$407.63m	n/a	n/a
PYCPYC Therapeutics	AU$391.95m	n/a	n/a
CGSCogstate	AU$239.92m	31.14	n/a
RACRace Oncology	AU$199.47m	n/a	n/a
DXBDimerix	AU$153.42m	n/a	n/a
PIQProteomics International Laboratories	AU$128.45m	n/a	n/a
ALAArovella Therapeutics	AU$118.25m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$86.12m	n/a	n/a
OCCOrthocell	AU$78.71m	n/a	n/a
PEBPacific Edge	NZ$83.50m	n/a	n/a
ACWActinogen Medical	AU$73.83m	n/a	n/a
PERPercheron Therapeutics	AU$69.42m	n/a	n/a
AGNArgenica Therapeutics	AU$58.00m	n/a	n/a
BITBiotron	AU$48.71m	n/a	n/a
ADOAnteotech	AU$46.13m	n/a	n/a